- OUTREACH, RECRUITMENT, AND EDUCATION CORE Since its inception, the Mayo Outreach, Recruitment, and Education Core (OREC;formerly the Education & Information Transfer Core) has actively served our patients, their caregivers, local communities, and care providers through both independent and collaborative efforts. Going forward under the new application, our activities align closely with the goals of the National Plan to Address Alzheimer's Disease to increase awareness of ADRC activity, educate the public about AD and non-AD dementia, partner with care providers across all levels to enhance dementia care quality and efficiency, and provide education and support programs to patients with dementia and their families. To achieve these goals, our core will leverage electronic and social media and deliver new and innovative support programs for patients and caregivers. We will continue to assist the Clinical Core in recruitment and retention of participants for center and center-related studies, including clinical trials and national biomarker and genetics initiatives. We will extend our outreach and educational activities to support the center-affiliated Mayo Clinic Study of Aging, which shares data on cognitively normal older adults with ADRC investigators. Importantly, the Mayo OREC will provide education, support services, and programs to traditionally underserved populations (i.e., rural residents in Rochester;African American elders in Jacksonville), thereby facilitating representation of these demographics in ADRC research. ADRC investigators and personnel will continue to support OREC goals by participating in educational programs and activities in international, national, regional, local, and institutional venues. These activities include traditional research presentations at scientific meetings, training and education of professionals and paraprofessionals, and support and education services for patients and caregivers. We will continue to contribute to the leadership of, and work synergistically with, the Alzheimer's Association, organizations representing the interests of patients with non-AD dementia, and other local, state, and national entities invested in dementia education and patient care needs. We will continue to promote and cultivate programs to educate and train the next generation of dementia investigators and clinicians by providing access to high quality, evidence-based training activities and continuing to partner with Mayo's Clinical and Translational Science Award (CTSA) program. We will also continue our tradition of strongly supporting junior and minority investigators. In summary, the OREC going forward will maintain its past strengths, address all requirements of the current RFP, and continue to support the Center in achieving its recruitment goals.

Public Health Relevance

- OUTREACH, RECRUITMENT, AND EDUCATION CORE The Mayo OREC provides the highest quality, innovative outreach, education, and supportive activities to families, caregivers, healthcare providers, and patients with MCI, AD, and related dementias. Core activities align closely with the goals of the National Plan to Address Alzheimer's Disease to increase awareness of ADRC activity, educate the public about AD and non-AD dementia, partner with care providers across all levels to enhance dementia care quality and efficiency, and provide education and support programs to patients with dementia and their families. These activities support recruitment and retention goals of the Mayo ADRC clinical core and provide unique opportunities to train the next generation of dementia-focused clinicians and junior investigators through participation in innovative, evidence-based service delivery programs and cooperation with the Mayo Clinical and Translational Science Award Program.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
2P50AG016574-16
Application #
8676250
Study Section
Special Emphasis Panel (ZAG1)
Project Start
2014-05-01
Project End
2019-04-30
Budget Start
2014-05-01
Budget End
2015-04-30
Support Year
16
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Raman, Mekala R; Shu, Yunhong; Lesnick, Timothy G et al. (2017) Regional T1 relaxation time constants in Ex vivo human brain: Longitudinal effects of formalin exposure. Magn Reson Med 77:774-778
Jun, Gyungah R; Chung, Jaeyoon; Mez, Jesse et al. (2017) Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimers Dement 13:727-738
McCarter, Stuart J; St Louis, Erik K; Sandness, David J et al. (2017) Diagnostic REM sleep muscle activity thresholds in patients with idiopathic REM sleep behavior disorder with and without obstructive sleep apnea. Sleep Med 33:23-29
Rogers, Justin T; Liu, Chia-Chen; Zhao, Na et al. (2017) Subacute ibuprofen treatment rescues the synaptic and cognitive deficits in advanced-aged mice. Neurobiol Aging 53:112-121
Sanchez-Contreras, Monica; Heckman, Michael G; Tacik, Pawel et al. (2017) Study of LRRK2 variation in tauopathy: Progressive supranuclear palsy and corticobasal degeneration. Mov Disord 32:115-123
Pichler, Michael; Vemuri, Prashanthi; Rabinstein, Alejandro A et al. (2017) Prevalence and Natural History of Superficial Siderosis: A Population-Based Study. Stroke 48:3210-3214
Vemuri, Prashanthi; Lowe, Val J; Knopman, David S et al. (2017) Tau-PET uptake: Regional variation in average SUVR and impact of amyloid deposition. Alzheimers Dement (Amst) 6:21-30
Whitwell, Jennifer L; Lowe, Val J; Tosakulwong, Nirubol et al. (2017) [18 F]AV-1451 tau positron emission tomography in progressive supranuclear palsy. Mov Disord 32:124-133
Raman, Mekala R; Tosakulwong, Nirubol; Zuk, Samantha M et al. (2017) Influence of preeclampsia and late-life hypertension on MRI measures of cortical atrophy. J Hypertens 35:2479-2485
Tripodis, Yorghos; Alosco, Michael L; Zirogiannis, Nikolaos et al. (2017) The Effect of Traumatic Brain Injury History with Loss of Consciousness on Rate of Cognitive Decline Among Older Adults with Normal Cognition and Alzheimer's Disease Dementia. J Alzheimers Dis 59:251-263

Showing the most recent 10 out of 900 publications